Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating ... - WELT ONLINE PDF Print
WELT ONLINEThe incidence of serious adverse events considered drug-related was low, with one event (mild renal impairment) reported in the Viread group and none

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.